All Stories

  1. Biological therapy in psoriatic patients whishing fatherhood: a multi‐centre italian experience in real life
  2. Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
  3. Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
  4. A real‐life experience of psoriatic patients with history of cancer treated with biological drugs
  5. Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study
  6. Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience
  7. Psoriasis and pregnancy outcomes in biological therapies: a real‐life, multi‐centre experience
  8. Pruritus characteristics in a large Italian cohort of psoriatic patients
  9. Use of ustekinumab in five psoriatic patients with hepatitis B virus infection
  10. Evaluation of generalized pustular psoriasis by reflectance confocal microscopy
  11. Switching from Secukinumab to Ustekinumab in Psoriasis Patients: Results from a Multicenter Experience
  12. Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy
  13. Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies
  14. Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
  15. Italian Guidelines in Pemphigus - adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV)
  16. How to improve adherence to treatment in patients with mild-to-moderate psoriasis
  17. Seminal Cell Free DNA Concentration Levels Discriminate Between Prostate Cancer and Benign Prostatic Hyperplasia
  18. Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers
  19. Secukinumab: A positive outcome in a patient with severe psoriasis and HBV-HCV co-infection
  20. Secukinumab in multi-failure psoriatic patients: the last hope?
  21. Consensus on the management of patients with psoriatic arthritis in a dermatology setting
  22. Ineffectiveness of infliximab CT-P13 for the treatment of scleromyxedema: A case report
  23. Psoriasis improvement after gastric bandage in a patient partial responder to infliximab
  24. Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
  25. Non-invasive evaluation of Secukinumab efficacy in severe plaque psoriasis with confocal microscopy and optical coherence tomography: A case report
  26. Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting
  27. Clinical features and in vivo reflectance confocal microscopy of an atypical presentation of Herpesvirus-2 and Cytomegalovirus co-infection of the intergluteal sulcus
  28. Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study
  29. Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis
  30. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature
  31. Efficacy of ustekinumab after failure of infliximab CT-P13 in a HLA-Cw6-positive patient affected by pityriasis rubra pilaris: monitoring with reflectance confocal microscopy (RCM) and optical coherence tomography (OCT)
  32. Long-term efficacy of high doses of intravenous immunoglobulins in generalized scleromyxoedema: Case report
  33. Speckled variance optical coherence tomography for the assessment of nail involvement in acrodermatitis continua of Hallopeau: A case study
  34. Welcome message from TPC chairs
  35. Down-titration of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study
  36. Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-TNF-α monoclonal antibody: an observational multicenter study
  37. Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry
  38. PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithm
  39. Monoclonal Gammopathy of Undetermined Significance in Patients with Psoriasis: Is it Really a Side Effect of Biological Therapy?
  40. Management of Patients with Psoriasis Treated with Biological Drugs Needing a Surgical Treatment
  41. Comments on “Diet and psoriasis, part I: Impact of weight loss interventions”
  42. Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: sphenoid asymmetry in a patient with a novelPTCH1mutation
  43. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity
  44. Diet and physical exercise in psoriasis: a randomized controlled trial
  45. Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry
  46. Validation and Field Performance of the Italian Version of the Psoriatic Arthritis Screening and Evaluation (PASE) Questionnaire
  47. Efficacy and Safety of Systemic Treatments for Psoriasis in Elderly Patients
  48. Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
  49. Section 1: Psoriasis
  50. Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study
  51. The somatic affairs ofBRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations
  52. Psoriasis plaque test with confocal microscopy: evaluation of different microscopic response pathways in NSAID and steroid treated lesions
  53. Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies
  54. Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry
  55. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis
  56. Psodisk, a new visual method for assessing the burden of psoriasis on patients
  57. VTC 2011 Spring TPC Co-Chairs
  58. Annular Lichenoid Dermatitis of Youth … and Beyond: A Series of 6 Cases
  59. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study
  60. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells
  61. Cutaneous metastases as the first manifestation of pleural malignant mesothelioma
  62. 725. Correction of Laminin-5-Deficient Junctional Epidermolysis Bullosa by Transplantation of Genetically Modified Epidermal Stem Cells. A Phase-I Clinical Trial
  63. No Increased Skin Reactivity in Subjects with Allergic Rhinitis During the Active Phase of the Disease: Clinical Report
  65. In vivo assessment of n-alkyl-sulfate-induced skin irritation by means of non-invasive methods
  66. P137 Erosive pustular dermatosis of the scalp: A case report
  67. Contact sensitization to preservatives in children
  68. Sensitization to reactive textile dyes in patients with contact dermatitis
  69. No Alteration of Biophysical Parameters in the Skin of Subjects with Respiratory Atopy
  70. Sensitization to white petrolatum used as a vehicle for patch testing
  71. Capacitance, transepidermal water loss and causal level of sebum in healthy subjects in relation to site, sex and age